“Collaboration is always better than competition”
-Paul Zamecnik, MD (1912-2009), “Father of Antisense Therapy”, Cofounder of ZATA

ZATA invites interested parties for a collaborative development of its future products:
– New generation oligotherapeutics (ZONs)
– Donated blood purification disposables (ZAP-Systems)
– New Inactivators (ZCIs) for enhanced efficacy killed vaccines

ZATA’s strength is its robust platform technologies:
  – Nucleic acid therapeutics enabling ZONs
  – Antipathogens enabling ZAP-systems and killed vaccine candidates